The long-awaited solution for personalized medicine

Saved in:
Bibliographic Details
Published inFrontiers in science (Lausanne) Vol. 3
Main Authors Khorkova, Olga, Wahlestedt, Claes
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 26.06.2025
Subjects
lipid nanoparticles
magistral production
nucleic acid therapeutics
personalized medicine
rare diseases
regulatory compliance
Online AccessGet full text

Cover

Author Khorkova, Olga
Wahlestedt, Claes
Author_xml – sequence: 1
  givenname: Olga
  surname: Khorkova
  fullname: Khorkova, Olga
– sequence: 2
  givenname: Claes
  surname: Wahlestedt
  fullname: Wahlestedt, Claes
BookMark eNpNkMtKAzEYhYNUsNY-gLt5gan5k3SSLKV4KRTc1HX4J5eaMp2UpCL69E5tKa7O4Rz4Ft8tGfWp94TcA51xrvRDKDbOGGXzGTRMUwZXZMwU8LrhnI7-9RsyLWVLKR26VEyNCV9_-KpL_abGL4wH76qSus9DTH0VUq72PpfUYxd_hmfnXbSx93fkOmBX_PScE_L-_LRevNart5fl4nFVW5gD1LLBtmXCSue8dRLQgZdWU4oogbWtDFQMi-IahJPCqcCCt5JZwT0F0fAJWZ64LuHW7HPcYf42CaP5G1LeGMyHaDtvuLJSD1zloBWuka2QyJGpxmvtaGgHFpxYNqdSsg8XHlBzlGiOEs1RojlL5L_Ga2cO
Cites_doi 10.1016/S2214-109X(24)00056-1
10.57264/cer-2023-0187
10.1007/s40273-022-01197-9
10.1056/NEJMoa1813279
10.1186/s13023-017-0695-0
10.1038/s41573-023-00704-7
10.1007/s12325-023-02621-y
10.3389/fsci.2025.1458636
10.1016/j.ajhg.2025.02.017
ContentType Journal Article
DBID AAYXX
CITATION
DOA
DOI 10.3389/fsci.2025.1629021
DatabaseName CrossRef
DOAJ Open Access Full Text
DatabaseTitle CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
EISSN 2813-6330
ExternalDocumentID oai_doaj_org_article_38c79aa78d1b4d67b47a3a286e99d0fb
10_3389_fsci_2025_1629021
GroupedDBID 9T4
AAFWJ
AAYXX
ALMA_UNASSIGNED_HOLDINGS
CITATION
GROUPED_DOAJ
M~E
ID FETCH-LOGICAL-c1511-76abb24c7ddecd71ad1e7c900aa712bb7f041e783914d74d8f2fec72c43e01463
IEDL.DBID DOA
ISSN 2813-6330
IngestDate Wed Aug 27 01:29:43 EDT 2025
Thu Jul 10 07:44:52 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1511-76abb24c7ddecd71ad1e7c900aa712bb7f041e783914d74d8f2fec72c43e01463
OpenAccessLink https://doaj.org/article/38c79aa78d1b4d67b47a3a286e99d0fb
ParticipantIDs doaj_primary_oai_doaj_org_article_38c79aa78d1b4d67b47a3a286e99d0fb
crossref_primary_10_3389_fsci_2025_1629021
PublicationCentury 2000
PublicationDate 2025-6-26
PublicationDateYYYYMMDD 2025-06-26
PublicationDate_xml – month: 06
  year: 2025
  text: 2025-6-26
  day: 26
PublicationDecade 2020
PublicationTitle Frontiers in science (Lausanne)
PublicationYear 2025
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Estapé Senti (B1) 2025; 3
Zhu (B7) 2024; 13
López-Bastida (B10) 2017; 12
(B5) 2025
Cheerie (B2) 2025; 112
Toro (B8) 2023; 40
Landfeldt (B9) 2023; 41
Khorkova (B3) 2023; 22
(B6) 2024; 12
Kim (B4) 2019; 381
References_xml – volume: 12
  start-page: e341
  year: 2024
  ident: B6
  article-title: The landscape for rare diseases in 2024
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(24)00056-1
– volume: 13
  start-page: e230187
  year: 2024
  ident: B7
  article-title: Evaluation of inpatient and emergency department healthcare resource utilization and costs pre- and post-nusinersen for the treatment of spinal muscular atrophy using United States claims
  publication-title: J Comp Eff Res
  doi: 10.57264/cer-2023-0187
– volume: 41
  year: 2023
  ident: B9
  article-title: Caregiver burden of spinal muscular atrophy: a systematic review
  publication-title: Pharmacoeconomics
  doi: 10.1007/s40273-022-01197-9
– volume: 381
  year: 2019
  ident: B4
  article-title: Patient-customized oligonucleotide therapy for a rare genetic disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1813279
– volume: 12
  start-page: 141
  year: 2017
  ident: B10
  article-title: Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain
  publication-title: Orphanet J Rare Dis
  doi: 10.1186/s13023-017-0695-0
– volume: 22
  year: 2023
  ident: B3
  article-title: Amplifying gene expression with RNA-targeted therapeutics
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/s41573-023-00704-7
– volume-title: Electronic Code of Federal Regulations. National Archives
  year: 2025
  ident: B5
  article-title: Part 211—Current good manufacturing practice for finished pharmaceuticals [21 CFR Part 211]
– volume: 40
  year: 2023
  ident: B8
  article-title: Health care resource utilization and costs for patients with spinal muscular atrophy: findings from a retrospective US claims database analysis
  publication-title: Adv Ther
  doi: 10.1007/s12325-023-02621-y
– volume: 3
  year: 2025
  ident: B1
  article-title: NANOSPRESSO: toward personalized, locally produced nucleic acid nanomedicines
  publication-title: Front Sci
  doi: 10.3389/fsci.2025.1458636
– volume: 112
  year: 2025
  ident: B2
  article-title: Consensus guidelines for assessing eligibility of pathogenic DNA variants for antisense oligonucleotide treatments
  publication-title: Am J Hum Genet
  doi: 10.1016/j.ajhg.2025.02.017
SSID ssj0003307828
Score 2.2957165
SourceID doaj
crossref
SourceType Open Website
Index Database
SubjectTerms lipid nanoparticles
magistral production
nucleic acid therapeutics
personalized medicine
rare diseases
regulatory compliance
Title The long-awaited solution for personalized medicine
URI https://doaj.org/article/38c79aa78d1b4d67b47a3a286e99d0fb
Volume 3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV09SwQxEA1iZSOKiucXW1gJ8TbZbCYpVe44hLPy4LqQTxvZO-REsPC3O9kPOSsbmxRJWJI3y7w3JLwQci2kZcB4pLYWnopoLXVBJRoTF7WXwobW1Gf-JGcL8bisl1tPfeU7YZ09cAfcuFIetLWgAnMiSHACbGW5klHrUCaXsy9y3lYxlXMwVulIfao7xsQqTI8zo2A5yOtbJrkuOftFRFt-_S2xTA_Ifq8Ii7tuJYdkJzZHpMLwFa-r5oXaD5tVYTH8IwWqzGI9SOhPHBmOx4_JYjp5fpjR_n0D6pFnGQVpnePCA6YYH4DZwCJ4XZa4Xcadg1QK7EEJw0QAgRDyFD1wL6qYPV-qE7LbrJp4Sgpdx9JrxSrQKPmTtLwEroLyySYeIY3IzbBZs-5sLAzK_4yMyciYjIzpkRmR-wzHz8TsQN12YFxMHxfzV1zO_uMj52QvLyxfzeLyguxu3t7jJYqAjbtq443t_GvyDeKCsTk
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+long-awaited+solution+for+personalized+medicine&rft.jtitle=Frontiers+in+science+%28Lausanne%29&rft.au=Olga+Khorkova&rft.au=Claes+Wahlestedt&rft.date=2025-06-26&rft.pub=Frontiers+Media+S.A&rft.eissn=2813-6330&rft.volume=3&rft_id=info:doi/10.3389%2Ffsci.2025.1629021&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_38c79aa78d1b4d67b47a3a286e99d0fb
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2813-6330&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2813-6330&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2813-6330&client=summon